Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Ribociclib (LEE011) Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube or Peritoneum

NCT03673124 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT03673124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03673124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Ribociclib (LEE011) Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube or Peritoneum
Lead sponsor
Gynecologic Oncology Group
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 20, 2019
Completion date
December 31, 2026
Enrollment
51 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

low grade serous carcinoma